Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Erlotinib | 0.031623 | uM | 8 | 625.00 | 218.83 | 4259.00 | 3970.75 | 1.0726 | 1.0338 |
| MCF 10A | Lapatinib | 0.31623 | uM | 8 | 625.00 | 218.83 | 4482.00 | 3970.75 | 1.1288 | 1.0588 |
| MCF 10A | 17-AAG | 0.0001 | uM | 8 | 625.00 | 218.83 | 4479.00 | 3970.75 | 1.1280 | 1.0584 |
| MCF 10A | 0 | uM | 8 | 625.00 | 218.83 | 3878.00 | 3970.75 | 0.9766 | 0.9887 | |
| MCF 10A | 17-AAG | 0.000302 | uM | 8 | 625.00 | 218.83 | 4222.00 | 3970.75 | 1.0633 | 1.0296 |
| MCF 10A | Erlotinib | 10 | uM | 8 | 625.00 | 218.83 | 230.00 | 3970.75 | 0.0579 | 0.0120 |
| MCF 10A | 17-AAG | 0.001 | uM | 8 | 625.00 | 218.83 | 3596.00 | 3970.75 | 0.9056 | 0.9531 |
| MCF 10A | Lapatinib | 10 | uM | 8 | 625.00 | 218.83 | 199.00 | 3970.75 | 0.0501 | -0.0225 |
| MCF 10A | 0 | uM | 8 | 625.00 | 218.83 | 4846.00 | 3970.75 | 1.2204 | 1.0976 | |
| MCF 10A | 0 | uM | 8 | 625.00 | 218.83 | 4117.00 | 3970.75 | 1.0368 | 1.0174 | |
| MCF 10A | 17-AAG | 0.000066069 | uM | 8 | 625.00 | 218.83 | 3358.00 | 3970.75 | 0.8457 | 0.9214 |
| MCF 10A | 0 | uM | 8 | 625.00 | 218.83 | 3602.00 | 3970.75 | 0.9071 | 0.9539 | |
| MCF 10A | 0 | uM | 8 | 625.00 | 218.83 | 3763.00 | 3970.75 | 0.9477 | 0.9745 | |
| MCF 10A | 0 | uM | 8 | 625.00 | 218.83 | 3501.00 | 3970.75 | 0.8817 | 0.9407 | |
| MCF 10A | 0 | uM | 8 | 625.00 | 218.83 | 3136.00 | 3970.75 | 0.7898 | 0.8903 | |
| MCF 10A | Erlotinib | 0.01 | uM | 8 | 625.00 | 218.83 | 3290.00 | 3970.75 | 0.8286 | 0.9120 |
| MCF 10A | Erlotinib | 3.1623 | uM | 8 | 625.00 | 218.83 | 259.00 | 3970.75 | 0.0652 | 0.0411 |
| MCF 10A | 17-AAG | 0.31623 | uM | 8 | 625.00 | 218.83 | 182.00 | 3970.75 | 0.0458 | -0.0431 |
| MCF 10A | Linsitinib | 19.9526 | uM | 8 | 625.00 | 218.83 | 512.00 | 3970.75 | 0.1289 | 0.2254 |
| MCF 10A | Linsitinib | 0.01 | uM | 8 | 625.00 | 218.83 | 4359.00 | 3970.75 | 1.0978 | 1.0451 |
| MCF 10A | Linsitinib | 0.031623 | uM | 8 | 625.00 | 218.83 | 3925.00 | 3970.75 | 0.9885 | 0.9945 |
| MCF 10A | Lapatinib | 0.01 | uM | 8 | 625.00 | 218.83 | 4455.00 | 3970.75 | 1.1220 | 1.0558 |
| MCF 10A | 17-AAG | 0.031623 | uM | 8 | 625.00 | 218.83 | 243.00 | 3970.75 | 0.0612 | 0.0254 |
| MCF 10A | Lapatinib | 0.1 | uM | 8 | 625.00 | 218.83 | 4455.00 | 3970.75 | 1.1220 | 1.0558 |
| MCF 10A | Erlotinib | 0.31623 | uM | 8 | 625.00 | 218.83 | 3986.00 | 3970.75 | 1.0038 | 1.0018 |